Veradermics (MANE) Short-term Investments (2025 - 2026)
Veradermics' Short-term Investments was $500.56 million in Q2 2026, up 125.1% from the prior quarter.
Powered by 
Analysis
Veradermics (MANE) Short-term Investments (2025 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Veradermics came in at $120.1 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.57 Bn | 1,139.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 641.68 Bn | 560.21 Bn | 17.26 Bn |
| 3 | AbbVie | 502.16 Bn | 475.27 Bn | 12.70 Bn |
| 4 | Merck | 375.54 Bn | 329.92 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.70 Bn | 266.69 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.54 Bn | 242.22 Bn | 12.86 Bn |
| 7 | Amgen | 242.61 Bn | 198.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.36 Bn | 167.56 Bn | 6.22 Bn |
| 9 | Pfizer | 172.54 Bn | 119.18 Bn | 10.94 Bn |
| 10 | Veradermics | 5.65 Bn | 4.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500.56 Mn |
| Mar 31, 2026 | 222.39 Mn |
| Dec 31, 2025 | 120.10 Mn |
API Access
Veradermics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=MANE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "MANE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=MANE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();